首页> 外文期刊>Expert opinion on therapeutic targets >NF-kappaB in carcinoma therapy and prevention.
【24h】

NF-kappaB in carcinoma therapy and prevention.

机译:NF-κB在癌症的治疗和预防中。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: NF-kappaB includes a family of signal-activated transcription factors that normally regulate responses to injury and infection but which are aberrantly activated in many carcinomas. OBJECTIVE: To review the activation and role of NF-kappaB in pathogenesis and as a target for treatment and prevention in carcinoma. METHODS: Evidence from experimental, epidemiological, preclinical studies and clinical trials cited in the literature are reviewed. RESULTS/CONCLUSION: Cumulative evidence implicates NF-kappaB in cell survival, inflammation, angiogenesis, spread and therapeutic resistance during tumor development, progression and metastasis of carcinomas. Non-specific natural and synthetic agents that inhibit NF-kappaB have demonstrated activity and safety in prevention or therapy. NF-kappaB-activating kinases and the proteasome are under investigation for targeted prevention and therapy of carcinoma.
机译:背景:NF-κB包括一类信号激活的转录因子,通常可调节对损伤和感染的反应,但在许多癌症中均被异常激活。目的:探讨NF-κB的激活及其在发病中的作用,并将其作为治疗和预防癌症的靶标。方法:综述了文献中引用的来自实验,流行病学,临床前研究和临床试验的证据。结果/结论:累积证据提示NF-kappaB在肿瘤发展,进展和转移过程中与细胞存活,炎症,血管生成,扩散和治疗抵抗有关。抑制NF-κB的非特异性天然和合成药物已证明在预防或治疗中具有活性和安全性。 NF-κB活化激酶和蛋白酶体正在研究中,用于靶向预防和治疗癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号